Real‐world outcomes of chemoradiotherapy for unresectable Stage III non‐small cell lung cancer: The SOLUTION study

There are limited real‐world data on the treatment practices, outcomes, and safety of chemoradiotherapy (CRT) alone in potential candidates for immune checkpoint inhibitors (ICI) for unresectable non‐small cell lung cancer (NSCLC). In this study, we analyzed the safety and efficacy of CRT in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Horinouchi, Hidehito, Atagi, Shinji, Oizumi, Satoshi, Ohashi, Kadoaki, Kato, Tomohiro, Kozuki, Toshiyuki, Seike, Masahiro, Sone, Takashi, Sobue, Tomotaka, Tokito, Takaaki, Harada, Hideyuki, Maeda, Tadashi, Mio, Tadashi, Shirosaka, Ikue, Hattori, Kana, Shin, Eisei, Murakami, Haruyasu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520333/
https://www.ncbi.nlm.nih.gov/pubmed/32730697
http://dx.doi.org/10.1002/cam4.3306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520333/
https://www.ncbi.nlm.nih.gov/pubmed/32730697
http://dx.doi.org/10.1002/cam4.3306

Ejemplares similares